{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T01:26:53Z","timestamp":1789349213500,"version":"build-2803163510"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,18]],"date-time":"2014-11-18T00:00:00Z","timestamp":1416268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1038\/nrrheum.2014.194","type":"journal-article","created":{"date-parts":[[2014,11,18]],"date-time":"2014-11-18T07:56:32Z","timestamp":1416297392000},"page":"8-9","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Seronegative and seropositive RA: alike but different?"],"prefix":"10.1038","volume":"11","author":[{"given":"Sofia","family":"Ajeganova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom W. J.","family":"Huizinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,18]]},"reference":[{"key":"BFnrrheum2014194_CR1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrrheum.2011.204","volume":"8","author":"A Willemze","year":"2012","unstructured":"Willemze, A., Trouw, L. A., Toes, R. E. & Huizinga, T. W. The influence of ACPA status and characteristics on the course of RA. Nat. Rev. Rheumatol. 8, 144\u2013152 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum2014194_CR2","doi-asserted-by":"publisher","unstructured":"Barra, L.  et al. Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritis. J. Rheumatol. \n                    http:\/\/dx.doi.org\/10.3899\/jrheum.140082\n                    \n                  .","DOI":"10.3899\/jrheum.140082"},{"key":"BFnrrheum2014194_CR3","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.3899\/jrheum.121438","volume":"40","author":"YM De Punder","year":"2013","unstructured":"De Punder, Y. M.  et al. Should we redefine treatment targets in rheumatoid arthritis? Low disease activity is sufficiently strict for patients who are anticitrullinated protein antibody-negative. J. Rheumatol. 40, 1268\u20131274 (2013).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2014194_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1136\/annrheumdis-2011-200379","volume":"71","author":"M Van den Broek","year":"2012","unstructured":"Van den Broek, M.  et al. The association of treatment response and joint damage with ACPA-status in recent-onset RA: a subanalysis of the 8-year follow-up of the BeSt study. Ann. Rheum. Dis. 71, 245\u2013248 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2014194_CR5","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/rheumatology\/ker516","volume":"51","author":"D Van der Woude","year":"2012","unstructured":"Van der Woude, D.  et al. Sustained drug-free remission in rheumatoid arthritis after DAS-driven or non-DAS-driven therapy: a comparison of two cohort studies. Rheumatology (Oxford) 51, 1120\u20131128 (2012).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2014194_CR6","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1186\/ar4439","volume":"16","author":"SD Seegobin","year":"2014","unstructured":"Seegobin, S. D.  et al. ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial. Arthritis Res. Ther. 16, R13 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2014194_CR7","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1136\/annrheumdis-2011-200736","volume":"71","author":"K Wevers-de Boer","year":"2012","unstructured":"Wevers-de Boer, K.  et al. Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study). Ann. Rheum. Dis. 71, 1472\u20131477 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2014194_CR8","doi-asserted-by":"publisher","first-page":"R180","DOI":"10.1186\/ar3505","volume":"13","author":"DP De Rooy","year":"2011","unstructured":"De Rooy, D. P., Willemze, A., Mertens, B., Huizinga, T. W. & Van der Helm-van Mil, A. H. Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes? Arthritis Res. Ther. 13, R180 (2011).","journal-title":"Arthritis Res. Ther."},{"issue":"Suppl. 2","key":"BFnrrheum2014194_CR9","doi-asserted-by":"publisher","first-page":"ii132","DOI":"10.1136\/annrheumdis-2012-202349","volume":"72","author":"LA Trouw","year":"2013","unstructured":"Trouw, L. A., Huizinga, T. W. & Toes, R. E. Autoimmunity in rheumatoid arthritis: different antigens\u2014common principles. Ann. Rheum. Dis. 72 (Suppl. 2), ii132\u2013ii136 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2014194_CR10","doi-asserted-by":"publisher","first-page":"17372","DOI":"10.1073\/pnas.1114465108","volume":"108","author":"J Shi","year":"2011","unstructured":"Shi, J.  et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc. Natl Acad. Sci. USA 108, 17372\u201317377 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2014.194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2014.194","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2014.194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:35:10Z","timestamp":1684470910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2014.194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,18]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["BFnrrheum2014194"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2014.194","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,18]]},"assertion":[{"value":"18 November 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}